About
KILYOS NUTRITION

With over 20 years’ experience in the
Brazilian nutrition market, Kilyos
Nutrition presents a portfolio
which includes the main
suppliers of raw materials for
human nutrition.

Partnerships with industry leading companies
In the early 1990s, Kilyos was responsible for the introduction of Albion™ mineral amino acid chelates into the Brazilian market, the only source of chelated minerals with proven chelation, becoming Albion’s exclusive representative in Brazil.

In 2014, Kilyos presented vitamin K2 MenaQ7®, the only source available with clinical validation and approved patents.

Two years later, Kilyos expanded its portfolio by joining Balchem™, delivering to the market the most researched choline brand.

In 2019, it added astaxanthin from AstaReal®, world leader and pioneer in the commercial production of natural astaxanthin.

And in 2021, Kilyos expanded its portfolio with the arrival of Phanteryx™, an American company operating in the biotechnology industry, with products derived from bovine colostrum. And Longvida®, an innovative ingredient supported by more than 25 clinical studies and considered the world’s leading source of turmeric.

Kilyos’ expertise combined with its suppliers’ high-end technology, enables it to deliver the very best solutions for the pharmaceutical and food industries in South America.

Science is part of Kilyos’ DNA
Committed to science, Kilyos works to ensure that its customers develop innovative and effective products with a strong scientific basis at the highest level possibly. Furthermore, it provides all the necessary support for this process.

Kilyos’ role is to understand the needs of each client and to present the alternatives that its portfolio can offer to add more value to its clients’ final product.

In this scenario, the Kilyos Science Lab was created: a methodology based on four processes.

And in 2021, Kilyos expanded its portfolio with the arrival of Phanteryx™, an American company operating in the biotechnology industry, with products derived from bovine colostrum. And in 2021, Kilyos expanded its portfolio with the arrival of Phanteryx™, an American company operating in the biotechnology industry, with products derived from bovine colostrum. And Longvida®, an innovative ingredient supported by more than 25 clinical studies and considered the world’s leading source of turmeric.

Kilyos’ expertise combined with its suppliers’ high-end technology, enables it to deliver the very best solutions for the pharmaceutical and food industries in South America.

Kilyos’ role is to understand the needs of each client and to present the alternatives that its portfolio can offer to add more value to its clients’ final product.

In this scenario, the Kilyos Science Lab was created: a methodology based on four processes.

KILYOS SCIENCE LAB

Brainstorming

Market trends, needs and business opportunities.

Strategy

Product development: Composition and dosages based on clinical studies and guidelines.

Regulatory analysis and format analysis (tablets, soft gels, liquids).

Implementation

Development of monographs, promotional material and sales force training.

Product Launch And Support

Result analysis and long- term support (new clinical studies and guidelines);

E-learning platform, periodic training, medical-scientific conferences.

SUPPORT CLINICAL RESEARCH IN BRAZIL

Clinical studies on the effects of nutritional supplementation on the population are very important for Kilyos. Therefore, in a commitment to science and seeking to improve the quality of life of the Brazilian population, Kilyos encourages research conducted in our country.

Kilyos seeks to create links with researchers and institutions that have an interest in clinical guidelines. If you are a researcher and are interested in conducting studies with products in our portfolio, please contact us for more details.

About
KILYOS NUTRITION